Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2)
Open Access
- 1 November 2006
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 116 (11), 3035-3041
- https://doi.org/10.1172/jci28953
Abstract
Genomic disorders are conditions that result from DNA rearrangements, such as deletions or duplications. The identification of the dosage-sensitive gene(s) within the rearranged genomic interval is important for the elucidation of genes responsible for complex neurobehavioral phenotypes. Smith-Magenis syndrome is associated with a 3.7-Mb deletion in 17p11.2, and its clinical presentation is caused by retinoic acid inducible 1 (RAI1) haploinsufficiency. The reciprocal microduplication syndrome, dup(17)(p11.2p11.2), manifests several neurobehavioral abnormalities, but the responsible dosage-sensitive gene(s) remain undefined. We previously generated a mouse model for dup(17)(p11.2p11.2), Dp(11)17/+, that recapitulated most of the phenotypes observed in human patients. We have now analyzed compound heterozygous mice carrying a duplication [Dp(11)17] in one chromosome 11 along with a null allele of Rai1 in the other chromosome 11 homologue [Dp(11)17/Rai1– mice] in order to study the relationship between Rai1 gene copy number and the Dp(11)17/+ phenotypes. Normal disomic Rai1 gene dosage was sufficient to rescue the complex physical and behavioral phenotypes observed in Dp(11)17/+ mice, despite altered trisomic copy number of the other 18 genes present in the rearranged genomic interval. These data provide a model for variation in copy number of single genes that could influence common traits such as obesity and behavior.This publication has 35 references indexed in Scilit:
- A genome-wide comparison of recent chimpanzee and human segmental duplicationsNature, 2005
- RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletionsJournal of Medical Genetics, 2005
- Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith–Magenis syndromeHuman Molecular Genetics, 2005
- Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith–Magenis syndromeHuman Molecular Genetics, 2004
- Detection of large-scale variation in the human genomeNature Genetics, 2004
- Animal models for human contiguous gene syndromes and other genomic disordersGenetics and Molecular Biology, 2004
- Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2)Human Molecular Genetics, 2003
- Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) Contiguous Gene Syndromes by Chromosome Engineering in Mice: Phenotypic Consequences of Gene Dosage ImbalanceMolecular and Cellular Biology, 2003
- Familial interstitial 570 kbp deletion of the UBE3A gene region causing Angelman syndrome but not Prader‐Willi syndromeAmerican Journal of Medical Genetics, 2002
- Positive selection of a gene family during the emergence of humans and African apesNature, 2001